We would love to hear your thoughts about our site and services, please take our survey here.
Looks Like Pollen Street capital bidding for Matiloi Woods is the trigger here. Makes sense they would then wrap this into to it too. But does that represent a risk of delisting rather than making a high bid?
Broadly I agree, but in 6 months the EV has to be £3m, in 12 months at least £4m, and so on. This is cash that is being spent, and if it's not spent in ways that increase the EV, the share price will keep falling, because the EV will still only be £2m
The best financial advisers I know recommend Transact, and one of the things that makes them the best financial advisers, is they attract/coach (its a virtuous circle) clients who understand and have enough to wealth to require their assets to increase, rather than be spent down. That sustaining an income in retirement, or more importantly a lifestyle, requires a growing pot.
This looks way overdone to me. I can understand HL falls because they face a lot of price competition from AJBell for an open platform and Vanguard for a single provider, but in adviser world there are different decisions going on.
I agree. Obviously the sales team are targeting those who are the buyers within trusts and hospitals and maybe the legal teams who might tell hospitals to buy Bleepa, but having pressure from below, 'I have this app, and I want to use it' could be really good. That's the way facebook grew across US college campuses
tb, they were both me.
I previously held a big stake (for me) here but couldn't afford to be patient here last year with so many other opportunities. Most of those have now passed (I missed some crackers) so I am now building up again. I was born at the Royal Berks hospital, so hoping they know a good thing when they see it lol
elartu and ged on advfn have both been consistently helpful and friendly posters